The Use of Imaging in the Diagnosis and Staging of Hepatobiliary Malignancies

Surgical Oncology Clinics of North America

Volumn 16, Issue 2, 2007, Pages 343-368

  Miller, George ^a   Schwartz, Lawrence H ^a   D'Angelica, Michael ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; ECHOGRAPHY; GALLBLADDER CANCER; HEPATOBILIARY SYSTEM TUMOR; HUMAN; IMAGING SYSTEM; LIVER BIOPSY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; TREATMENT PLANNING;

BILIARY TRACT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSTIC IMAGING; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 34249874594     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2007.04.001     Document Type: Review

References (85)

1. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
2. Sherman M. Surveillance for hepatocellular carcinoma. Semin Oncol 28 (2001) 450-459
3. Zhang B.H., Yang B.H., and Tang Z.Y. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130 (2004) 417-422
4. Terjung B., Lemnitzer I., Dumoulin F.L., et al. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 67 (2003) 138-145
5. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
6. Lei H.J., Chau G.Y., Lui W.Y., et al. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg 203 (2006) 426-435
7. Ramacciato G., Mercantini P., Cautero N., et al. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol 12 (2005) 289-297
8. Marrero J.A., Fontana R.J., Barrat A., et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41 (2005) 707-716
9. Grieco A., Pompili M., Caminiti G., et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Gut 54 (2005) 411-418
10. Cillo U., Bassanello M., Vitale A., et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?. J Hepatol 40 (2004) 124-131
11. Dodd III G.D., Miller W.J., Baron R.L., et al. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique. AJR Am J Roentgenol 159 (1992) 727-733
12. Tanaka S., Ioka T., Oshikawa O., et al. Dynamic sonography of hepatic tumors. AJR Am J Roentgenol 177 (2001) 799-805
13. Wen Y.L., Kudo M., Zheng R.Q., et al. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol 182 (2004) 1019-1026
14. Ralls P.W. Color Doppler sonography of the hepatic artery and portal venous system. AJR Am J Roentgenol 155 (1990) 517-525
15. Peterson M.S., Baron R.L., Marsh Jr. J.W., et al. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 217 (2000) 743-749
16. Miller W.J., Baron R.L., Dodd III G.D., et al. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 193 (1994) 645-650
17. Baron R.L., Oliver III J.H., Dodd III G.D., et al. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 199 (1996) 505-511
18. Brancatelli G., Federle M.P., Grazioli L., et al. Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents. Radiology 222 (2002) 89-94
19. Stevens W.R., Gulino S.P., Batts K.P., et al. Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J Comput Assist Tomogr 20 (1996) 337-342
20. Cho K.C., Patel Y.D., Wachsberg R.H., et al. Varices in portal hypertension: evaluation with CT. Radiographics 15 (1995) 609-622
21. Krinsky G.A., Lee V.S., Theise N.D., et al. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging. Liver Transpl 8 (2002) 1156-1164
22. Libbrecht L., Bielen D., Verslype C., et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 8 (2002) 749-761
23. Rode A., Bancel B., Douek P., et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 25 (2001) 327-336
24. Kamel I.R., and Bluemke D.A. MR imaging of liver tumors. Radiol Clin North Am 41 (2003) 51-65
25. Ebara M., Fukuda H., Kojima Y., et al. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 210 (1999) 81-88
26. Mitchell D.G., Rubin R., Siegelman E.S., et al. Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Radiology 178 (1991) 101-103
27. Jeong Y.Y., Mitchell D.G., and Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178 (2002) 1327-1334
28. Wudel Jr. L.J., Delbeke D., Morris D., et al. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg 69 (2003) 117-124
29. Trojan J., Schroeder O., Raedle J., et al. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 94 (1999) 3314-3319
30. Sugiyama M., Sakahara H., Torizuka T., et al. 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma. J Gastroenterol 39 (2004) 961-968
31. Nagaoka S., Itano S., Ishibashi M., et al. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Liver Int 26 (2006) 781-788
32. Chen Y.K., Hsieh D.S., Liao C.S., et al. Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence. Anticancer Res 25 (2005) 4719-4725
33. Yang S.H., Suh K.S., Lee H.W., et al. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl 12 (2006) 1655-1660
34. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33 (2001) 1353-1357
35. Yamamoto S., Kubo S., Hai S., et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 95 (2004) 592-595
36. Koh K.C., Lee H., Choi M.S., et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 189 (2005) 120-125
37. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10 (2003) 288-291
38. Kim T.K., Choi B.I., Han J.K., et al. Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings. Radiology 204 (1997) 539-543
39. Lacomis J.M., Baron R.L., Oliver III J.H., et al. Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 203 (1997) 98-104
40. Asayama Y., Yoshimitsu K., Irie H., et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 238 (2006) 150-155
41. Soyer P., Bluemke D.A., Hruban R.H., et al. Intrahepatic cholangiocarcinoma: findings on spiral CT during arterial portography. Eur J Radiol 19 (1994) 37-42
42. Miura F., Okazumi S., Takayama W., et al. Evaluation of CT during arterial portography for preoperative diagnosis of intrahepatic cholangiocarcinoma. Hepatogastroenterology 53 (2006) 435-437
43. Valls C., Guma A., Puig I., et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 25 (2000) 490-496
44. Han J.K., Choi B.I., Kim A.Y., et al. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 22 (2002) 173-187
45. Manfredi R., Barbaro B., Masselli G., et al. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 24 (2004) 155-164
46. Vilgrain V., Van Beers B.E., Flejou J.F., et al. Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21 (1997) 59-65
47. Zhang Y., Uchida M., Abe T., et al. Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 23 (1999) 670-677
48. Kim Y.J., Yun M., Lee W.J., et al. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30 (2003) 1467-1472
49. Jarnagin W.R., Fong Y., Dematteo R.P., et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234 (2001) 507-517
50. Heslin M.J., Brooks A.D., Hochwald S.N., et al. A preoperative biliary stent is associated with increased complications after pancreatoduodenectomy. Arch Surg 133 (1998) 149-154
51. Hochwald S.N., Burke E.C., Jarnagin W.R., et al. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 134 (1999) 261-266
52. Nimura Y., Kamiya J., Kondo S., et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 7 (2000) 155-162
53. Kondo S., Hirano S., Ambo Y., et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 240 (2004) 95-101
54. Looser C., Stain S.C., Baer H.U., et al. Staging of hilar cholangiocarcinoma by ultrasound and duplex sonography: a comparison with angiography and operative findings. Br J Radiol 65 (1992) 871-877
55. Neumaier C.E., Bertolotto M., Perrone R., et al. Staging of hilar cholangiocarcinoma with ultrasound. J Clin Ultrasound 23 (1995) 173-178
56. Bach A.M., Hann L.E., Brown K.T., et al. Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 201 (1996) 149-154
57. Hanninen E.L., Pech M., Jonas S., et al. Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol 46 (2005) 462-470
58. Manfredi R., Masselli G., Maresca G., et al. MR imaging and MRCP of hilar cholangiocarcinoma. Abdom Imaging 28 (2003) 319-325
59. Manfredi R., Brizi M.G., Masselli G., et al. [Malignant biliary hilar stenosis: MR cholangiography compared with direct cholangiography]. Radiol Med (Torino) 102 (2001) 48-54 [in Italian]
60. Cha J.H., Han J.K., Kim T.K., et al. Preoperative evaluation of Klatskin tumor: accuracy of spiral CT in determining vascular invasion as a sign of unresectability. Abdom Imaging 25 (2000) 500-507
61. Lee H.Y., Kim S.H., Lee J.M., et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239 (2006) 113-121
62. Kato T., Tsukamoto E., Kuge Y., et al. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 29 (2002) 1047-1054
63. Fritscher-Ravens A., Bohuslavizki K.H., Broering D.C., et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22 (2001) 1277-1285
64. Shirai Y., Yoshida K., Tsukada K., et al. Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg 215 (1992) 326-331
65. Yamaguchi K., and Tsuneyoshi M. Subclinical gallbladder carcinoma. Am J Surg 163 (1992) 382-386
66. Hawkins W.G., Dematteo R.P., Jarnagin W.R., et al. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 11 (2004) 310-315
67. Rodriguez-Fernandez A., Gomez-Rio M., Medina-Benitez A., et al. Application of modern imaging methods in diagnosis of gallbladder cancer. J Surg Oncol 93 (2006) 650-664
68. Kimura K., Fujita N., Noda Y., et al. Differential diagnosis of large-sized pedunculated polypoid lesions of the gallbladder by endoscopic ultrasonography: a prospective study. J Gastroenterol 36 (2001) 619-622
69. Onoyama H., Yamamoto M., Takada M., et al. Diagnostic imaging of early gallbladder cancer: retrospective study of 53 cases. World J Surg 23 (1999) 708-712
70. Wibbenmeyer L.A., Sharafuddin M.J., Wolverson M.K., et al. Sonographic diagnosis of unsuspected gallbladder cancer: imaging findings in comparison with benign gallbladder conditions. AJR Am J Roentgenol 165 (1995) 1169-1174
71. Komatsuda T., Ishida H., Konno K., et al. Gallbladder carcinoma: color Doppler sonography. Abdom Imaging 25 (2000) 194-197
72. Sadamoto Y., Kubo H., Harada N., et al. Preoperative diagnosis and staging of gallbladder carcinoma by EUS. Gastrointest Endosc 58 (2003) 536-541
73. Kim B.S., Ha H.K., Lee I.J., et al. Accuracy of CT in local staging of gallbladder carcinoma. Acta Radiol 43 (2002) 71-76
74. Yun E.J., Cho S.G., Park S., et al. Gallbladder carcinoma and chronic cholecystitis: differentiation with two-phase spiral CT. Abdom Imaging 29 (2004) 102-108
75. Kumar A., and Aggarwal S. Carcinoma of the gallbladder: CT findings in 50 cases. Abdom Imaging 19 (1994) 304-308
76. Yoshimitsu K., Honda H., Shinozaki K., et al. Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection. AJR Am J Roentgenol 179 (2002) 423-428
77. Ohtani T., Shirai Y., Tsukada K., et al. Spread of gallbladder carcinoma: CT evaluation with pathologic correlation. Abdom Imaging 21 (1996) 195-201
78. Kumaran V., Gulati S., Paul B., et al. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol 12 (2002) 1993-1999
79. Winston C.B., Chen J.W., Fong Y., et al. Recurrent gallbladder carcinoma along laparoscopic cholecystectomy port tracks: CT demonstration. Radiology 212 (1999) 439-444
80. Tseng J.H., Wan Y.L., Hung C.F., et al. Diagnosis and staging of gallbladder carcinoma. Evaluation with dynamic MR imaging. Clin Imaging 26 (2002) 177-182
81. Kim J.H., Kim T.K., Eun H.W., et al. Preoperative evaluation of gallbladder carcinoma: efficacy of combined use of MR imaging, MR cholangiography, and contrast-enhanced dual-phase three-dimensional MR angiography. J Magn Reson Imaging 16 (2002) 676-684
82. Schwartz L.H., Black J., Fong Y., et al. Gallbladder carcinoma: findings at MR imaging with MR cholangiopancreatography. J Comput Assist Tomogr 26 (2002) 405-410
83. Rodriguez-Fernandez A., Gomez-Rio M., Llamas-Elvira J.M., et al. Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosis. Am J Surg 188 (2004) 171-175
84. Koh T., Taniguchi H., Yamaguchi A., et al. Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET). J Surg Oncol 84 (2003) 74-81
85. Anderson C.D., Rice M.H., Pinson C.W., et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8 (2004) 90-97